{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:02:24Z","timestamp":1790679744301,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>SARS-CoV-2 is the major cause of infections in humans since December 2019 and is top of the global health concern currently. <jats:italic>Streptococcus pneumoniae<\/jats:italic> is one of the\u00a0leading pathogens of invasive bacterial diseases, including pneumonia, sepsis, and meningitis. Moreover, this bacteria is mostly responsible for secondary infections subsequent to post-viral respiratory disease. Co-infections with bacterial and viral pathogens are associated with severe course of the disease and are a major cause of mortality. In this report, we describe a rare case of COVID-19 patient with pneumococcal sepsis and meningitis of unsuccessful course.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 89-year-old man, not vaccinated against SARS-CoV-2 infection, was diagnosed with COVID-19 pneumonia. Patient required oxygen therapy due to respiratory failure. The initial treatment of viral infection with tocilizumab and dexamethasone allowed for the stabilization of the patient\u2019s condition and improvement of laboratory parameters. On the 9th day of hospitalization the patient\u2019s condition deteriorated. Consciousness disorders and acute respiratory disorders requiring intubation and mechanical ventilation were observed. Brain computed tomography excluded intracranial bleeding. The <jats:italic>Streptococcus pneumoniae<\/jats:italic> sepsis with concomitant pneumoniae and meningitis was diagnosed based on microbiological culture of blood, bronchial wash, and cerebrospinal fluid examination. Despite targeted antibiotic therapy with ceftriaxone and multidisciplinary treatment, symptoms of multiple organ failure increased. On the 13th day of hospitalization, the patient died.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Co-infections with bacterial pathogens appear to be not common among COVID-19 patients, but may cause a sudden deterioration of the general condition. Not only vascular neurological complications, but also meningitis should be always considered in patients with sudden disturbances of consciousness. Anti-inflammatory treatment with the combination of corticosteroids and tocilizumab (or tocilizumab alone) pose a severe risk for secondary lethal bacterial or fungal infections. Thus, treating a high-risk population (i.e. elderly and old patients) with these anti-inflammatory agents, require daily clinical assessment, regular monitoring of C-reactive protein and procalcitonin, as well as standard culture of blood, urine and sputum in order to detect concomitant infections, as rapidly as possible.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07156-1","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T13:03:20Z","timestamp":1645621400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pneumococcal meningitis and COVID-19: dangerous coexistence. A case report"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2646-364X","authenticated-orcid":false,"given":"Katarzyna","family":"Guziejko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Czupryna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa Katarzyna","family":"Zielenkiewicz-Madejska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Moniuszko-Malinowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"issue":"8","key":"7156_CR1","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AA, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782\u201393. https:\/\/doi.org\/10.1001\/jama.2020.12839.","journal-title":"JAMA"},{"issue":"8","key":"7156_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fpubh.2020.00383","volume":"29","author":"N Chams","year":"2020","unstructured":"Chams N, Chams S, Badran R, Shams A, Araji A, et al. COVID-19: a multidisciplinary review. Front Public Health. 2020;29(8):383. https:\/\/doi.org\/10.3389\/fpubh.2020.00383.","journal-title":"Front Public Health"},{"key":"7156_CR3","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.GPP3-0004-2018","author":"AJ Loughran","year":"2019","unstructured":"Loughran AJ, Orihuela CJ, Tuomanen EI. Streptococcus pneumoniae: invasion and inflammation. Microbiol Spectr. 2019. https:\/\/doi.org\/10.1128\/microbiolspec.GPP3-0004-2018.","journal-title":"Microbiol Spectr"},{"issue":"6","key":"7156_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198772","volume":"13","author":"AM Oordt-Speets","year":"2018","unstructured":"Oordt-Speets AM, Bolijn R, van Hoorn RC, Bhavsar A, Kyaw MH. Global etiology of bacterial meningitis: a systematic review and meta-analysis. PLoS ONE. 2018;13(6): e0198772. https:\/\/doi.org\/10.1371\/journal.pone.0198772.","journal-title":"PLoS ONE"},{"key":"7156_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coi.2015.02.002","volume":"34","author":"KM Robinson","year":"2015","unstructured":"Robinson KM, Kolls JK, Alcorn JF. The immunology of influenza virus-associated bacterial pneumonia. Curr Opin Immunol. 2015;34:59\u201367. https:\/\/doi.org\/10.1016\/j.coi.2015.02.002 (Epub 2015 Feb 24).","journal-title":"Curr Opin Immunol"},{"issue":"10","key":"7156_CR6","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1128\/IAI.00298-15","volume":"83","author":"A Rynda-Apple","year":"2015","unstructured":"Rynda-Apple A, Robinson KM, Alcorn JF. Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease. Infect Immun. 2015;83(10):3764\u201370. https:\/\/doi.org\/10.1128\/IAI.00298-15.","journal-title":"Infect Immun"},{"issue":"5","key":"7156_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/irv.12398","volume":"10","author":"EY Klein","year":"2016","unstructured":"Klein EY, Monteforte B, Gupta A, Jiang W, May L, et al. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses. 2016;10(5):394\u2013403. https:\/\/doi.org\/10.1111\/irv.12398 (Epub 2016 Jun 24).","journal-title":"Influenza Other Respir Viruses"},{"issue":"4","key":"7156_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","volume":"27","author":"BJ Langford","year":"2021","unstructured":"Langford BJ, So M, Raybardhan S, Leung V, Soucy J-PR, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27(4):520\u201331. https:\/\/doi.org\/10.1016\/j.cmi.2020.12.018 (Epub 2021 Jan 5).","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"7156_CR9","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","volume":"71","author":"TM Rawson","year":"2020","unstructured":"Rawson TM, Moore LS, Zhu N, Ranganathan N, Skolimowska K, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459\u201368. https:\/\/doi.org\/10.1093\/cid\/ciaa530.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"7156_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmi.2020.09.025","volume":"27","author":"TM Rawson","year":"2021","unstructured":"Rawson TM, Wilson RC, Holmes A. Understanding the role of bacterial and fungal infection in COVID-19. Clin Microbiol Infect. 2021;27(1):9\u201311. https:\/\/doi.org\/10.1016\/j.cmi.2020.09.025 (Epub 2020 Oct 9).","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"7156_CR11","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1007\/s00415-021-10406-y","volume":"268","author":"BN Harapan","year":"2021","unstructured":"Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol. 2021;268(9):3059\u201371. https:\/\/doi.org\/10.1007\/s00415-021-10406-y.","journal-title":"J Neurol"},{"issue":"350","key":"7156_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577436","volume":"7","author":"K Keyhanian","year":"2020","unstructured":"Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, et al. SARS-CoV-2 and nervous system: from pathogenesis to clinical manifestation. J Neuroimmunol. 2020;7(350): 577436. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577436.","journal-title":"J Neuroimmunol"},{"issue":"11","key":"7156_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3389\/fneur.2020.00518","volume":"22","author":"MU Ahmed","year":"2020","unstructured":"Ahmed MU, Hanif M, Jamat Ali MJ, Haider MA, Kheran D, et al. Neurological manifestations of COVID-19 (SARS-CoV-2): a review. Front Neurol. 2020;22(11):518. https:\/\/doi.org\/10.3389\/fneur.2020.00518.","journal-title":"Front Neurol"},{"issue":"6","key":"7156_CR14","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1016\/S2589-7500(21)00077-7","volume":"3","author":"AB Brueggemann","year":"2021","unstructured":"Brueggemann AB, Jansen van Rensburg MJ, Shaw D, McCarthy ND, Jolley KA, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive respiratory infection surveillance initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3(6):e360\u201370. https:\/\/doi.org\/10.1016\/S2589-7500(21)00077-7.","journal-title":"Lancet Digit Health"},{"issue":"2","key":"7156_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3201\/eid1002.030638","volume":"10","author":"KK Lau","year":"2004","unstructured":"Lau KK, Yu WC, Chu CM, Lau ST, Sheng B, et al. Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis. 2004;10(2):342. https:\/\/doi.org\/10.3201\/eid1002.030638.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"7156_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neurad.2020.06.007","volume":"48","author":"S Katal","year":"2021","unstructured":"Katal S, Balakrishnan S, Gholamrezanezhad A. Neuroimaging and neurologic findings in COVID-19 and other coronavirus infections: a systematic review in 116 patients. J Neuroradiol. 2021;48(1):43\u201350. https:\/\/doi.org\/10.1016\/j.neurad.2020.06.007.","journal-title":"J Neuroradiol"},{"key":"7156_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","volume":"94","author":"T Moriguchi","year":"2020","unstructured":"Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, et al. A first case of meningitis\/encephalitis associated with SARS-coronavirus-2. Int J Infect Dis. 2020;94:55\u20138. https:\/\/doi.org\/10.1016\/j.ijid.2020.03.062.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"7156_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s13365-020-00923-3","volume":"27","author":"R Mondal","year":"2021","unstructured":"Mondal R, Ganguly U, Deb S, Shome G, Pramanik S, et al. Meningoencephalitis associated with COVID-19: a systematic review. J Neurovirol. 2021;27(1):12\u201325. https:\/\/doi.org\/10.1007\/s13365-020-00923-3.","journal-title":"J Neurovirol"},{"issue":"Suppl 3","key":"7156_CR19","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","volume":"22","author":"D van de Beek","year":"2016","unstructured":"van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT, ESCMID Study Group for Infections of the Brain (ESGIB), et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22(Suppl 3):S37\u201362. https:\/\/doi.org\/10.1016\/j.cmi.2016.01.007.","journal-title":"Clin Microbiol Infect"},{"key":"7156_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0163-4453(83)96980-3","volume":"7","author":"V Bohr","year":"1983","unstructured":"Bohr V, Rasmussen N, Hansen B, Kjersem H, Jessen O, et al. 875 cases of bacterial meningitis: diagnostic procedures and the impact of preadmission antibiotic therapy. Part III of a three-part series. J Infect. 1983;7:193\u2013202.","journal-title":"J Infect"},{"key":"7156_CR21","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1542\/peds.2007-3275","volume":"122","author":"LE Nigrovic","year":"2008","unstructured":"Nigrovic LE, Malley R, Macias CG, Kanegaye JT, Moro-Sutherland DM, et al. Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis. Pediatrics. 2008;122:726\u201330. https:\/\/doi.org\/10.1542\/peds.2007-3275.","journal-title":"Pediatrics"},{"issue":"1","key":"7156_CR22","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1186\/s12879-021-06647-x","volume":"21","author":"N Palanisamy","year":"2021","unstructured":"Palanisamy N, Vihari N, Meena DS, Kumar D, Midha N, et al. Clinical profile of bloodstream infections in COVID-19 patients: a retrospective cohort study. BMC Infect Dis. 2021;21(1):933. https:\/\/doi.org\/10.1186\/s12879-021-06647-x.","journal-title":"BMC Infect Dis"},{"issue":"Suppl 2","key":"7156_CR23","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.cmi.2018.02.002","volume":"24","author":"KL Winthrop","year":"2018","unstructured":"Winthrop KL, Mariette X, Silva JT, Benamu E, Calabrese LH, et al. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors). Clin Microbiol Infect. 2018;24(Suppl 2):S21\u201340. https:\/\/doi.org\/10.1016\/j.cmi.2018.02.002.","journal-title":"Clin Microbiol Infect"},{"key":"7156_CR24","doi-asserted-by":"publisher","first-page":"R141","DOI":"10.1186\/ar3455","volume":"13","author":"MH Schiff","year":"2011","unstructured":"Schiff MH, Kremer JM, Jahreis A, Vernon E, Isaacs JD, et al. Integrated safety in tocilizumab clinical trials. Arthritis Res Ther. 2011;13:R141.","journal-title":"Arthritis Res Ther"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07156-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07156-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07156-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T13:04:08Z","timestamp":1645621448000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07156-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7156"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07156-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"assertion":[{"value":"11 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the relative of the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}